CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells

Journal of Cell Science

Volumn 117, Issue 15, 2004, Pages 3379-3388

  Murayama, Yoko ^a   Miyagawa, Jun Ichiro ^a   Oritani, Kenji ^a   Yoshida, Hitoshi ^a   Yamamoto, Katsumi ^a   Kishida, Osamu ^a   Miyazaki, Tamana ^a   Tsutsui, Shusaku ^a   Kiyohara, Tatsuya ^a   Miyazaki, Yoshiji ^a   Higashiyama, Shigeki ^b   Matsuzawa, Yuji ^a   Shinomura, Yasuhisa ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Cancer cells; CD9; Shc; Tetraspanin

Indexed keywords

CASPASE 3; CD9 ANTIGEN; ISOPROTEIN; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ALB6; PROTEIN P46; PROTEIN SHC; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANNEXIN A5; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; APOPTOSIS; CASPASE 3; CASPASES; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORING AGENTS; ENZYME ACTIVATION; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLASMIDS; PROTEIN ISOFORMS; THYMIDINE; TIME FACTORS; TRANSFECTION;

EID: 4344659148     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01201     Document Type: Review

References (51)

1. Anderson, C. N. G. and Tolkovsky, A. M. (1999). A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. J. Neurosci. 19, 664-673.
2. Aoyama, K., Oritani, K., Yokota, T., Ishikawa, J., Nishiura, T., Miyake, K., Kanakura, Y., Tomiyama, Y., Kincade, P. W. and Matsuzawa, Y. (1999). Stromal cell CD9 regulates differentiation of hematopoietic stem/progenitor cells. Blood 93, 2586-2594.
3. Baker, S. J. and Reddy, E. P. (1998). Modulation of life and death by the TNF receptor superfamily. Oncogene 17, 3261-3270.
4. Baudoux, B., Castanares-Zapatero, D., Leclercq-Smekens, M., Berna, N. and Poumay, Y. (2000). The tetraspanin CD9 associates with the integrin alpha6beta4 in cultured human epidermal keratinocytes and is involved in cell motility. Eur. J. Cell Biol. 79, 41-51.
5. Berditchevski, F. (2001). Complexes of tetraspanins with integrins: more than meets the eye. J. Cell Sci. 114, 4143-4151.
6. Berditchevski, F. and Odintsova, E. (1999). Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J. Cell Biol. 146, 477-492.
7. Berditchevski, F., Zutter, M. M, and Hemler, M. E. (1996). Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol. Biol. Cell 7, 193-207.
8. Buckley, S., Driscoll, B., Barsky, L., Weinberg, K., Anderson, K. and Warburton, D. (1999). ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. Am. J. Physiol. 277, L159-L166.
9. Boucheix, C., Soria, C., Mirshahi, M., Soria, J., Perrot, J. Y., Fournier, N., Billard, M. and Rosenfeld, C. (1983). Characterization of platelet aggregation induced by the monoclonal antibody ALB6 (acute lymphoblastic leukemia antigen p24). Inhibition of aggregation by ALB6 Fab. FEBS Lett. 16, 289-295.
10. Boulton, T. G., Nye, S. H., Robbins, D. J., Ip, N. Y., Radziejewska, E., Morgenbesser, S. D., Dephino, R. A., Panayotatos, N., Cobb, M. H. and Yancopoulos, G. D. (1991). ERK's: a family of protein serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65, 663-675.
11. Cajot, J. F., Sordat, I., Silvestre, T. and Sordat, B. (1997). Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res. 57, 2593-2597.
12. Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M. and Davis, R. J. (1994). JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037.
13. Erhardt, P., Schremser, E. J. and Cooper, G. M. (1999). B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol. Cell. Biol. 19, 5308-5315.
14. Gotoh, N., Toyoda, M. and Shibuya, M. (1997). Tyrosine phosphorylation sites at amino acid 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation. Mol. Cell. Biol. 17, 1824-1831.
15. Han, J., Lee, J. D., Bibbs, L. and Ulevitch, R. J. (1994). A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811.
16. Hemler, M. E. (2003). Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 19, 397-422.
17. Higashihara, M., Maeda, H., Shibata, Y., Kume, S. and Ohashi, T. (1985). A monoclonal anti-human platelet antibody: a new platelet aggregating substance. Blood 65, 382-391.
18. Higashiyama, S., Iwamoto, R., Goishi, K., Raab, G., Taniguchi, N., Klagsbrun, M. and Mekada, E. (1995). The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J. Cell Biol. 128, 929-938.
19. Inui, S., Higashiyama, S., Hashimoto, K., Higashiyama, M., Yoshikawa, K. and Taniguchi, N. (1997). Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth. J. Cell Physiol. 171, 291-298.
20. Jones, P. H., Bishop, L. A. and Watt, F. M. (1996). Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes. Cell Adhes. Commun. 4, 297-305.
21. Kroll, M. H., Mendelsohn, M. E., Miller, J. L., Ballen, K. K., Hrbolich, J. K. and Schafer, A. I. (1992). Monoclonal antibody AG-1 initiates platelet activation by a pathway dependent on glycoprotein IIb-IIIa and extracellular calcium. Biochim. Biophys. Acta 1137, 248-256.
22. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J. and Woodgett, J. R. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160.
23. Maecker, H. T., Todd, S. C. and Levy, S. (1997). The tetraspanin superfamily: molecular facilitators. FASEB J. 11, 428-442.
24. Mori, M., Mimori, K., Shiraishi, T., Haraguchi, M., Ueo, H., Barnard, G. F. and Akiyoshi, T. (1998). Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clin. Cancer Res. 4, 1507-1510.
25. Murayama, Y., Miyagawa, J., Shinomura, Y., Kanayama, S., Isozaki, K., Yamamori, K., Mizuno, H., Ishiguro, S., Kiyohara, T., Miyazaki, Y. et al. (2002). Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer. Int. J. Cancer 98, 505-513.
26. shc splicing isoforms on the EGF receptor-MAP kinase Fos signaling pathway. EMBO J. 16, 706-716.
27. shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309-313.
28. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
29. Nagata, Y. and Todokoro, K. (1999). Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94, 853-863.
30. Ohto, H., Shibata, Y., Takeuchi, A., Chen, R. F. and Maeda, H. (1985). Expression of the platelet-common acute lymphoblastic leukaemia associated antigen on normal eosinophils. Scand. J. Haematol. 34, 281-287.
31. Okada, S., Kao, A. W., Ceresa, B. P., Blaikie, P., Margolis, B. and Pessin, J. E. (1997). The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J. Biol. Chem. 272, 28042-28049.
32. Ono, M., Hanada, K., Witheres, D. A. and Hakomori, S. (1999). Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res. 59, 2335-2339.
33. Oritani, K., Wu, X., Medina, K., Hudson, J., Miyake, K., Gimble, J. M., Burstein, S. A. and Kincade, P. W. (1996). Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood 87, 2252-2261.
34. syk in human platelets. J. Biol. Chem. 270, 15119-15124.
35. ras. Mol. Cell. Biol. 14, 1575-1581.
36. Rozakis-Adcock, M., McGlade, J., Mbamalu, G., Pelicci, G., Daly, R., Li, W., Batzer, A., Thomas, S., Brugge, J., Pelicci, P. G. et al. (1992). Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinase. Nature 360, 689-692.
37. Rubinstein, E., le Naour, F., Lagaudriere-Gesbert, C., Billard, M., Conjeaud, H. and Boucheix, C. (1996). CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26, 2657-2665.
38. Seehafer, J. G. and Shaw, A. R. (1991). Evidence that the signal-initiating membrane protein CD9 is associated with small GTP-binding proteins. Biochem. Biophys. Res. Commun. 179, 401-406.
39. Shaw, A. R., Domanska, A., Mak, A., Ginichrist, A., Dobler, K., Visser, L., Poppema, S., Fliegel, L., Letarte, M. and Willett, B. J. (1995). Ectopic expression of human and feline CD9 in a human B cell line confers β1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J. Biol. Chem. 270, 24092-24099.
40. Shi, W., Fan, H., Shum, L. and Derynck, R. (2000). The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J. Cell Biol. 148, 591-602.
41. Sho, M., Adachi, M., Taki, T., Hashida, H., Konishi, T., Huang, C. L., Ikeda, N., Nakajima, Y., Kanehiro, H., Hisanaga, M. et al. (1998). Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int. J. Cancer 79, 509-516.
42. Sato, K., Nagao, T., Kakumoto, M., Kimoto, M., Otsuki, T., Iwasaki, T., Tokmakov, A. A., Owada, K. and Fukami, Y. (2002). Adaptor protein Shc is an isoform-specific direct activator of the tyrosine kinase c-Src. J. Biol. Chem. 277, 29568-29576.
43. Tachibana, I. and Hemler, M. E. (1999). Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J. Cell Biol. 146, 893-904.
44. Tai, X. G., Toyooka, K., Yashiro, Y., Abe, R., Park, C. S., Hamaoka, T., Kobayashi, M., Neben, S. and Fujiwara, H. (1997). CD9-mediated costimulation of TCR-triggered native T cells leads to activation followed by apoptosis. J. Immunol. 159, 3799-3807.
45. Uchida, S., Shimada, Y., Watanabe, G., Li, Z. G., Hong, T., Miyake, M. and Imamura, M. (1999). Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br. J. Cancer 79, 1168-1173.
46. Wang, X., Martindale, J. L., Liu, Y. and Holbrook, N. J. (1998). The cellular response to oxidative stress: influences of mitogen-activated protein kinase signaling pathways on cell survival. Biochem. J. 333, 291-300.
47. Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E. and Giancotti, F. G. (1996). The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 87, 733-743.
48. Widmann, C., Gibson, S. and Johnson, G. L. (1998). Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273, 7141-7147.
49. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J. and Greenberg, M. E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
50. Yáñez-Mó, M., Alfranca, A., Cabañas, C., Marazuela, M., Tejedor, R., Ursa, A., Ashman, L. K., de Landá zuri, M. O. and Sanchez-Madrid, F. (1998). Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TATP-1 and CD151/PETA-3 with α3β1 integrin localized at endothelial lateral junctions. J. Cell Biol. 141, 791-804.
51. Yatomi, Y., Ozaki, Y., Satoh, K. and Kume, S. (1993). Anti-CD9 monoclonal antibody elicits staurosporine inhibitable phosphatidylinositol 4, 5-bisphosphate hydrolysis, phosphatidylinositol 3,4-bisphosphate synthesis, and protein-tyrosine phosphorylation in human platelets. FEBS Lett. 322, 285-290.